Identification and characterization of homing peptides using in vivo peptide phage display

Methods in Molecular Biology

Volumn 1324, Issue , 2015, Pages 205-222

  Hyvönen, Maija ^a   Laakkonen, Pirjo ^a  

^a NONE

Author keywords

Brain tumor; Cell penetrating peptide; Ex vivo; In vivo; Nude mice; Phage display; T7; Tumor targeting; Vasculature

Indexed keywords

CELL PENETRATING PEPTIDE; PEPTIDE LIBRARY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER CELL; CONTROLLED STUDY; ENTEROBACTERIA PHAGE T7; EX VIVO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING; VASCULAR TUMOR; ANIMAL; BRAIN; BRAIN NEOPLASMS; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES; VASCULARIZATION;

MUS MUSCULUS;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE LIBRARY;

EID: 84938151903     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2806-4_14     Document Type: Article

References (30)

1. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE (2004) Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429:629-635
2. Ruoslahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2:83-90
3. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202
4. Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364-366
5. Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E (2002) Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A 99:1527-1531
6. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E (1998) Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 102:430-437
7. Zhang L, Hoffman JA, Ruoslahti E (2005) Molecular profiling of heart endothelial cells. Circulation 112:1601-1611
8. Burg MA, Pasqualini R, Arap W, Ruoslahti E, Stallcup WB (1999) NG2 proteoglycanbinding peptides target tumor neovasculature. Cancer Res 59:2869-2874
9. Laakkonen P, Porkka K, Hoffman JA, Ruoslahti E (2002) A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med 8:751-755
10. Pasqualini R, Koivunen E, Ruoslahti E (1997) Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 15: 542-546
11. Porkka K, Laakkonen P, Hoffman JA, Bernasconi M, Ruoslahti E (2002) A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc Natl Acad Sci U S A 99:7444-7449
12. Hoffman JA, Giraudo E, Singh M, Zhang L, Inoue M, Porkka K, Hanahan D, Ruoslahti E (2003) Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma. Cancer Cell 4:383-391
13. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D (2003) Stagespecific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 4:393-403
14. Laakkonen P, Zhang L, Ruoslahti E (2008) Peptide targeting of lymph vessels. Annu N Y Acad Sci 1131:37-43
15. Eriste E, Kurrikoff K, Suhorutsenko J, Oskolkov N, Copolovici DM, Jones S, Laakkonen P, Howl J, Langel U (2013) Peptide-based glioma-targeted drug delivery vector gHoPe2. Bioconjug Chem 24:305-313
16. Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E (2011) Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A 108:17450-17455
17. Hyvonen M, Enback J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Narvanen A, Bergers G, Laakkonen P (2014) Novel target for peptide-based imaging and treatment of brain tumors. Mol Cancer Ther 13:996-1007
18. Kinnari PJ, Hyvonen ML, Makila EM, Kaasalainen MH, Rivinoja A, Salonen JJ, Hirvonen JT, Laakkonen PM, Santos HA (2013) Tumour homing peptide- functionalized porous silicon nanovectors for cancer therapy. Biomaterials 34:9134-9141
19. Zahid M, Phillips BE, Albers SM, Giannoukakis N, Watkins SC, Robbins PD (2010) Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice. PLoS One 5, e12252
20. Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, EL Andaloussi S (2008) Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug Chem 19: 2535-2542
21. El Andaloussi S, Guterstam P, Langel U (2007) Assessing the delivery efficacy and internalization route of cell-penetrating peptides. Nat Protoc 2:2043-2047
22. Gump JM, Dowdy SF (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 13:443-448
23. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Girard OM, Hanahan D, Mattrey RF, Ruoslahti E (2009) Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16:510-520
24. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E (2009) C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A 106:16157-16162
25. Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, Ruoslahti E (2010) Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 328:1031-1035
26. Pang HB, Braun GB, She ZG, Kotamraju VR, Sugahara KN, Teesalu T, Ruoslahti E (2014) A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity. J Control Release 175:48-53
27. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317
28. Hoogenboom HR (2002) Overview of antibody phage-display technology and its applications. Methods Mol Biol 178:1-37
29. El-Andaloussi S, Johansson HJ, Holm T, Langel U (2007) A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids. Mol Ther 15:1820-1826
30. Zahid M, Robbins PD (2011) Identification and characterization of tissue-specific protein transduction domains using peptide phage display. Methods Mol Biol 683:277-289